PLAGL2 and hepatocellular carcinoma: As shown in Figure 9L, the immunostaining intensity of PLAGL2 and total/nuclear β‐catenin was much stronger in HCC tumor tissues with low miR‐378a‐3p expression than in those with high miR‐378a‐3p expression.